Categories

1. Excellence in Pharma: Innovation in Response to COVID-19 - NEW!

A new award for 2020 designed to recognise innovation in technologies, products, processes, and services to combat the impact of COVID-19 on individuals, patients, healthcare professionals and communities. Including but not limited to the development and manufacture of potential vaccines, drug products and medical equipment and the introduction of services, solutions and resources to provide support to those effected by the pandemic.

Criteria

• Innovation: How does the entry demonstrate innovation and resourcefulness in response to the pandemic?
• Purpose and Outcomes: Does it achieve its purpose? Does it offer benefits to the audience it was designed for? *
• Problem-solving: How does it address the impact of COVID-19? Does it do so in an effective way?
• Competitive Advantage: How does the entry demonstrate going above and beyond or a collaborative approach in a time of crisis?

* Given the short timeframes for response to the COVID-19 pandemic, we understand that many products or solutions will not yet have regulatory approval. Please submit as much evidence and support for your entry as is feasibly possible.

2. Excellence in Pharma: API Development

Innovation in technologies, products, processes, and services for the development and manufacture of active pharmaceutical ingredients (APIs) including, but not limited to, synthesis, characterization, formulation, scale-up, software and database development, bulk manufacturing.

Criteria

• Innovation: Does the entry introduce a new idea, device, method orFormulation novelty to the market?
• Purpose: Does it achieve its purpose? Does it offer benefits to the audience it was designed for?
• Problem-solving: Does it solve a problem? Does it address an issue in an effective way?
• Competitive Advantage: Does it offer a competitive advantage in the market and within its category?

3. Excellence in Pharma: Finished Formulation

Innovation in technologies, products, processes, and services related to the formulation of drug products including, but not limited to, excipients, finished dose, OTC, novel software and databases, process development, resolving formulation challenges such as solubility/ bioavailability enhancement, drug targeting or controlled release, solving stability issues such as protein aggregation, etc. Please note: to be eligible for this category, the activity must have taken place between 1 July 2017 and 30 June 2020

Criteria

• Innovation: Does the entry introduce a new idea, device, method or novelty to the market?
• Purpose: Does it achieve its purpose? Does it offer benefits to the audience it was designed for?
• Problem-solving: Does it solve a problem? Does it address an issue in an effective way?
• Competitive Advantage: Does it offer a competitive advantage in the market and within its category?

4. Excellence in Pharma: Manufacturing Technology and Equipment

Innovation in technologies, products, processes, and services for the manufacture of solid, semi-solid, parenteral, inhalation, or other dosage drugs including, but not limited to, equipment, manufacturing processes, facilities, process controls, and continuous manufacturing.

Criteria

• Innovation: Does the entry introduce a new idea, device, method or novelty to the market?
• Features: Does the product have interesting or important part(s), qualities, abilities, improved attributes?
• Problem-solving: Does it solve a problem? Does it address an issue in an effective way?
• Competitive Advantage: Does it offer a competitive advantage in the market and within its category?

5. Excellence in Pharma: Bioprocessing & Manufacturing

Innovation in technologies, products, processes, and services for the processing and manufacture of biologic-based drugs including, but not limited to, equipment, raw materials, cell lines, manufacturing processes, facilities, process controls, and continuous biomanufacturing.

Criteria

• Innovation: Does the entry introduce a new idea, device, method or novelty to the market?
• Features & Purpose: Does the product have interesting or important part(s), qualities, abilities, improved attributes? Does it achieve what it was intended to achieve? Does it offer benefits to the audience it was designed for?
• Problem-solving: Does it solve a problem? Does it address an issue in an effective way?
• Competitive Advantage: Does it offer a competitive advantage in the market and within its category?

6. Excellence in Pharma: Analysis, Testing, and Quality Control

Innovation in technologies, products, processes, and services for the analysis and testing of drug substances, raw materials, and drug products in a laboratory on production line setting including, but not limited to, laboratory instruments and equipment, analytical instruments, laboratory software, quality control tools, data integrity systems, and contract laboratory services.

Criteria

• Innovation: Does the entry introduce a new solution, idea, device, method or service to the market?
• Process Excellence: Does the product or service offer a series of actions of extremely high quality that produce something or that lead to an improved result?
• Problem-solving: Does it solve a problem? Does it address an issue in an effective way?
• Competitive Advantage: Does it offer a competitive advantage in the market and within its category?

7. Excellence in Pharma: Packaging

Innovation in technologies, products, processes, and services related to primary and secondary packaging of finished drug forms, and delivery of drug products to patients. Including, but not limited to, inhalers, auto-injectors, vials, syringes, patches, combination products, tamper-proof packaging, child-safety packaging, labelling, intelligent packaging, and fill-finish.

Criteria

• Innovation: Does the entry introduce a new idea, device, method or novelty to the market?
• Features & Purpose: Does the product have interesting or important part(s), qualities, abilities, improved attributes? Does it achieve what it was intended to achieve? Does it offer benefits to the audience it was designed for?
• Problem-solving: Does it solve a problem? Does it address an issue in an effective way?
• Competitive Advantage: Does it offer a competitive advantage in the market and within its category?

8. Excellence in Pharma: Drug Delivery Devices

Innovation in technologies, products, processes, and services related delivery of drug products to patients including, but not limited to, inhalers, auto-injectors, vials, syringes, patches, and combination products.

Criteria

• Innovation: Does the entry introduce a new idea, device, method or novelty to the market?
• Features & Purpose: Does the product have interesting or important part(s), qualities, abilities, improved attributes? Does it achieve what it was intended to achieve? Does it offer benefits to the audience it was designed for?
• Problem-solving: Does it solve a problem? Does it address an issue in an effective way?
• Competitive Advantage: Does it offer a competitive advantage in the market and within its category?

9. Excellence in Pharma: Digital Innovation

Innovation in digital technologies, products, processes, initiatives and services which drive value in pharmaceutical development and improve patient outcomes. Including but not limited to advanced and predictive analytics, Artificial Intelligence, automation, patient-centric solutions for improved experience and adherence, track and trace, remote monitoring, medical devices and wearables.

Criteria

• Innovation: Does the entry introduce a new idea, device, method, process or service to the market?
• Purpose: Does it achieve what it was intended to achieve? Does it offer benefits to the audience it was designed for?
• Problem-solving: Does it solve a problem? Does it address an issue in an effective way?
• Competitive Advantage: Does it offer a competitive advantage in the market and within its category?

10. Excellence in Pharma: Supply Chain, Logistics, and Distribution

Innovation in technologies, products, processes, and services for ensuring the safe handling and tracking of drug substances, raw materials, and finished drug products including, but not limited to, supply chain, audits, temperature-controlled logistics, transport services, track and trace, shipping containers, and distribution channels.

Criteria

• Innovation: Does the entry introduce a new idea, device, method or service to the market?
• Purpose: Does it achieve what it was intended to achieve? Does it offer benefits to the audience it was designed for?
• Problem-solving: Does it solve a problem? Does it address an issue in an effective way?
• Competitive Advantage: Does it offer a competitive advantage in the market and within its category?

11. Excellence in Pharma: Contract Services and Outsourcing

Innovation in contracted services and processes for the bio/pharmaceutical industry including, but not limited to, drug research, development, formulation, scale up, process development, clinical trial manufacturing, drug product manufacturing, API development and manufacturing, laboratory services, and consulting.

Criteria

• Innovation: Does the entry introduce a new idea, device, method or service to the market?
• Process Excellence: Does the product or service offer a series of actions of extremely high quality that produce something or that lead to an improved result?
• Problem-solving: Does it solve a problem? Does it address an issue in an effective way?
• Competitive Advantage: Does it offer a competitive advantage in the market and within its category?

12. Excellence in Pharma: Sustainability

This award recognizes sustainable development in the Pharmaceutical industry and innovative initiatives for improving outcomes for patients, employees, the environment and wider community. Including but not limited to, initiatives to minimise environmental impact, waste reduction, energy & utility saving solutions, sustainable and collaborative product development, innovative and sustainable use of resources, social outreach, employee training and mentoring programs, fair employee working policies, diversity and inclusion initiatives.

Criteria

• Implementation: Does the process of implementing the initiative include all of the activities that need to be done in order to effectuate actual change?
• Achievements: Has the entry/project performed with positive outcomes and high success rates?
• Positive Outcomes to Stakeholders: Did the entry/project provide good results to whoever was involved in or affected by a course of action of the respective company?
• Future Plans: Does the entry/project provide an opportunity for continuity or expansion?

13. Excellence in Pharma: Regulatory Procedures and Compliance

Innovation in technologies, products, processes, and services designed to aid and ensure that bio/pharma companies comply with standards, rules, and guidance documents established by regulatory authorities including, but not limited to, consulting services, development of consortia and industry groups, reference standards, educational programs, and software and IT, technologies, and equipment.

Criteria

• Innovation: Does the entry introduce a new idea, device, method or service to the market?
• Process Excellence: Does the product or service offer an improved process, leading to better outcomes and results?
• Problem-solving: Does it solve a problem? Does it address an issue in an effective way?
• Competitive Advantage: Does it offer a competitive advantage in the market and within its category?

14. Excellence in Pharma: CEO of the Year

C-Suite Executives of SME, Large Pharma/Biopharma or service providers are eligible for nomination. Attributes to be considered include, but are not limited to, financial performance, product performance, global reach, leadership skills, management capability, charitable initiatives, sustainability, regulatory compliance, profitability, vision, marketing, acquisitions, corporate strategy, and financing.

Criteria

• Dynamism: Is the nominee an exemplary leader with a strong desire to achieve – are they compelling, powerful, progressive?
• Lifetime Achievements: Has the CEO achieved or accomplished sustained growth, driven improved performance, implemented robust strategies, engaged staff and customers in their current role or throughout the course of their career?
• Leadership Qualities: Has the CEO consistent personal strengths and attributes that makes he or she an extraordinary leader?
• Contribution to the Wider Industry: Is the CEO committed to the development of the pharma industry - be in the form of donating goods, funding, time, market insights business intelligence, new lines of business?

15. Excellence in Pharma: Pharma Service Company of the Year

Bio/pharmaceutical companies and service providers that develop, produce, manufacture and market pharmaceutical products are eligible to be nominated.

Criteria

• Innovation: Has the organization demonstrated a new strategy, process, method or service to the market in the past 12 months which has had a significant impact?
• Depth & breadth of competencies: Has the organization received industry accolades or accreditations for products or services?
• Operational excellence: Has the organization demonstrated actions towards improving operational performance?
• Business Growth & Success: Has the organization carried out any specific activities or initiatives that have contributed to business growth? For example, progress in emerging markets. What achievements is the organization most proud of over the past year, how will you ensure continued success?
• Differentiation: What makes your organization stand out from the competition?